As a result of participating in this activity, learners will be able to: Discuss the role of Combined Modality Therapy for treatment of colorectal Liver metastasis, identify the sequence of Combined Modality Therapy in Liver Metastasis from Rectal cancer, and review indications and Contraindications for HIPEC in Colorectal Carcinomatosis.
The target audience for this presentation: Currently practicing physicians who actively see patients in Oncology, Radiation Oncology, Gastroenterology, and Family Medicine.
This activity has been approved for AMA PRA Category 1 Credit™
View related document for accreditation information.
CONTACT
If you have any questions or credit related inquiries, please contact USF Health at cpdsupport@usf.edu
Published
June 23, 2020
Created by
Presenters
Andreas Karachristos, FACS, MD, PhD
Chief of Surgical Oncology
Hepatobiliary and Pancreatic Surgery
Professor of Surgery
Department of Surgery
University of South Florida
Dr. Andreas Karachristos specializes in hepato-pancreato-biliary(HPB) or the care of the liver, pancreas, bile duct and gallbladder.
Assistant Professor
Division of Colon and Rectal Surgery
University of South Florida
Morsani College of Medicine
Assistant Professor at USF Health Morsani College of Medicine for the Division of Colon & Rectal Surgery